“Our algorithm was able to differentiate between the group of healthy volunteers and the group of patients with a record level of certainty for studies of this type: with an accuracy of 92%“, says Dr. Efrat Shema in a statement released by the Weizmann Institute of Science.
This method might simplify screenings from cancer colorectalcurrently detectable by colonoscopy, an invasive examination that frightens patients, and pancreatic cancerfor which there is no diagnostic test.
While this method still needs to be confirmed by clinical teststhe specialists hope that this approach will make it possible to diagnose different cancers as well as diseases leaving traces in the blood such as heart disease ou auto-immunes.
